Acadia Pharmaceuticals (ACAD) Change in Acquisitions & Divestments (2010 - 2026)

Acadia Pharmaceuticals' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $86.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 33.87% year-over-year to $86.5 million; the TTM figure through Mar 2026 stood at $449.2 million (up 14.23% YoY), while the FY2025 annual figure was $493.5 million, up 50.21% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $86.5 million, down from $105.8 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $259.4 million in Q1 2023, with the low at $7.5 million in Q2 2023.
• The 5-year median for Change in Acquisitions & Divestments is $103.8 million (2023), against an average of $104.4 million.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments sank 89.22% in 2023, then jumped 986.67% in 2024.
• Acadia Pharmaceuticals' Change in Acquisitions & Divestments stood at $75.8 million in 2022, then surged by 36.89% to $103.8 million in 2023, then rose by 7.8% to $111.8 million in 2024, then decreased by 5.45% to $105.8 million in 2025, then slipped by 18.2% to $86.5 million in 2026.
• Business Quant data shows ACAD's Change in Acquisitions & Divestments at $86.5 million in Q1 2026, $105.8 million in Q4 2025, and $125.6 million in Q3 2025.